Epstein-Barr virus (EBV) infects various cell types in a wide spectrum of benign and
malignant diseases. Laboratory tests for EBV have improved and are increasingly used in …

Primary varicella-zoster virus (VZV) infection (varicella) induces VZV-specific antibody and
VZV-specific T cell-mediated immunity. T cell-mediated immunity, which is detected within 1 …

SUMMARY Epstein-Barr virus (EBV) DNA measurement is being incorporated into routine
medical practice to help diagnose, monitor, and predict posttransplant lymphoproliferative …

Epstein‐Barr virus (EBV) has long been suggested as a pathogen in multiple sclerosis (MS).
Here, we used high‐throughput sequencing to determine the diversity …

Although immune signaling has emerged as a defining feature of the glioma
microenvironment, how the underlying structure of the glioma-infiltrating T-cell population …

EBV, a B lymphotropic herpesvirus, encodes two immediate early (IE)-,> 30 early (E)-, and>
30 late (L)-phase proteins during its replication (lytic) cycle. Despite this, lytic Ag-induced …

The ability to culture and expand B cells in vitro has become a useful tool for studying
human immunity. A limitation of current methods for human B cell culture is the capacity to …

Multiple Sclerosis (MS) is a chronic neurological disease with genetic and environmental
risk factors. Epstein Barr-Virus (EBV) has been closely associated with MS but with a …

Post-transplant lymphoproliferative disorder is a life-threatening complication of
immunosuppression following transplantation mediated by failure of T cells to control …

Background: Epstein–Barr Virus (EBV) infection is associated with a heterogeneous group
of tumors, including lymphoproliferative disorders, Hodgkin's disease, nasopharyngeal …